IP Library Granted Patent US 9,410,187
Granted Patent B2
US 9,410,187 · App. 14/459,083 · Granted Aug 9, 2016

Methods of using FET labeled oligonucleotides that include a 3′→5′ exonuclease resistant quencher domain and compositions for practicing the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,410,187
App. No.
14/459,083
Granted
Aug 9, 2016
Kind
B2
Abstract

Methods and compositions are provided for detecting a primer extension product in a reaction mixture. In the subject methods, a primer extension reaction is conducted in the presence of a polymerase having 3′→5′ exonuclease activity and at least one FET labeled oligonucleotide probe that includes a 3′→5′ exonuclease resistant quencher domain. Also provided are systems and kits for practicing the subject methods. The subject invention finds use in a variety of different applications, and are particularly suited for use in high fidelity PCR based reactions, including SNP detection applications, allelic variation detection applications, and the like.

Claims (21)

1. A method for detecting the production of a primer extension product in a primer extension reaction mixture, said method comprising:

(a) producing a primer extension mixture comprising a template nucleic acid, a nucleic acid polymerase having 3′→5′ exonuclease activity, and a FET labeled oligonucleotide comprising a target-binding sequence, a fluorophore, a nucleic acid intercalator, and a quencher, wherein said nucleic acid intercalator and said quencher are covalently bonded to the 3′ end of said FET labeled oligonucleotide;

(b) subjecting said primer extension mixture to primer extension reaction conditions; and

(c) detecting a fluorescent signal from said FET labeled oligonucleotide in said mixture, whereby a change in said fluorescent signal is indicative of the presence of a primer extension product in said mixture.

2. The method according to claim 1 , wherein said primer extension reaction is a PCR amplification reaction.

3. The method according to claim 2 , wherein said method is a real-time method of monitoring said PCR amplification reaction.

4. The method according to claim 1 , wherein said quencher is a dark quencher.

5. The method according to claim 4 , wherein energy transfer occurs between said fluorophore and dark quencher of said FET labeled oligonucleotide probe upon fluorophore excitation when said FET labeled oligonucleotide is not hybridized to target nucleic acid.

6. The method according to claim 5 , wherein energy transfer does not occur between said fluorophore and dark quencher of said FET labeled oligonucleotide probe upon fluorophore excitation when said FET labeled oligonucleotide probe is hybridized to a target nucleic acid.

7. The method according to claim 4 , wherein said dark quencher is a Black Hole Quencher.

8. The method according to claim 1 , wherein said FET labeled oligonucleotide is a probe selected from the group consisting of: a TAQMAN probe, a SCORPION probe, a SUNRISE probe, a molecular beacon, a conformationally assisted probes, and an in situ hybridization probe.

9. The method according to claim 1 , wherein said nucleic acid intercalator comprises a polycyclic compound.

10. The method according to claim 9 , wherein said polycyclic compound comprises an aromatic ring.

11. The method according to claim 9 , wherein said polycyclic compound comprises at least three rings and not more than six rings.

12. The method according to claim 9 , wherein said polycyclic compound comprises at least three rings, wherein at least two of said rings are fused.

13. The method according to claim 12 , wherein said polycyclic compound is an acridine.

14. The method according to claim 1 , wherein said nucleic acid intercalator is covalently bonded to said oligonucleotide through at least one linker.

15. The method according to claim 1 , wherein said nucleic acid intercalator is covalently bonded to the 3′ terminus of said oligonucleotide.

16. The method according to claim 15 , wherein said quencher is bonded to said nucleic acid intercalator.

17. The method according to claim 15 , wherein said quencher is bonded to the 3′ terminal nucleotide of the oligonucleotide.

18. The method according to claim 1 , wherein said quencher is covalently bonded to the 3′ terminus of said oligonucleotide.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2016
From: CHOU, QUIN; SPASIC, DRAGAN
To: BIOSOURCE INTERNATIONAL, INC.
Reel/Frame 038631/0760 →
MERGER AND CHANGE OF NAME Recorded May 18, 2016
From: BIOSOURCE INTERNATIONAL INC.; INVITROGEN CORPORATION
To: INVITROGEN CORPORATION
Reel/Frame 038631/0910 →
MERGER AND CHANGE OF NAME Recorded May 18, 2016
From: INVITROGEN CORPORATION; LIFE TECHNOLOGIES CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 038632/0169 →